LifeSci Capital. Patrick Dolezal. Piper Jaffray. Ted Tenthoff. Zacks. Brian Marckx $58.94 -0.86 (-1.44%) NASDAQ (ARWR) 4:00 PM EST - 01.09.20. Copyright View detailed financial information, real-time news, videos, quotes and analysis on Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR). Explore commentary on 15 May 2018 Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades. Corporate earnings are provided from Zacks Investment Research, including Income Stock Reports +. ARWR stock quote information – including stock price, key financials, stock charts and investing ideas containing ARWR. BioBoyScout's Proprietary Due Diligence, Analysis, Competitive. Intelligence, and Opinion on Arrowhead Pharmaceuticals, Inc. On portable devices, best 26 Sep 2019 Type of Stock recent addition and which ARWR hopes to have in clinical studies next Zacks Projected EPS Growth Rate - Next 5 Years %.
Zacks Investment Research‘s price target would suggest a potential upside of 18.67% from the stock’s previous close.
14/12/2019 · Equities research analysts expect Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) to post sales of $31.00 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Arrowhead Pharmaceuticals’ earnings. The highest sales estimate is $42.00 million and the lowest is $20.00 million. By Grant Zeng, CFA NASDAQ:ARWR Earlier today (March 5), Arrowhead (NASDAQ:ARWR) announced the acquisition of Novartis’ entire RNAi research and development portfolio and associated assets. The Deal The acquisition includes: · Multiple patent families covering RNAi-trigger design rules and modifications that fall outside of key patents For a free copy of the full research report, please email [email protected] with ARWR as the subject. SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR and to view our disclaimer. View the latest ARWR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ARROWHEAD PHARMACEUTICALS, INC.. View Arrowhead Pharmaceuticals' (NASDAQ:ARWR) earnings history, MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Fundamental company data provided by Morningstar and Zacks Investment Research. View detailed financial information, real-time news, videos, quotes and analysis on Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR). Explore commentary on Arrowhead Pharmaceuticals Inc. and hear what the experts at TheStreet are saying about ARWR. ARWR $58.94 ($-0.86 -1.44%) ARWR is down $0.86 today, but where's it headed in 2020? Zacks Investment Research is releasing its prediction for ARWR based on the 1-3 month system that more than doubles the S&P 500. This report is free today for StockInvest.us readers. Click here – …
Get today's Sea Ltd stock price and latest SE news as well as Sea real-time stock quotes, technical analysis, full financials and more.
14/12/2019 · Equities research analysts expect Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) to post sales of $31.00 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Arrowhead Pharmaceuticals’ earnings. The highest sales estimate is $42.00 million and the lowest is $20.00 million. By Grant Zeng, CFA NASDAQ:ARWR Earlier today (March 5), Arrowhead (NASDAQ:ARWR) announced the acquisition of Novartis’ entire RNAi research and development portfolio and associated assets. The Deal The acquisition includes: · Multiple patent families covering RNAi-trigger design rules and modifications that fall outside of key patents For a free copy of the full research report, please email [email protected] with ARWR as the subject. SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR and to view our disclaimer. View the latest ARWR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ARROWHEAD PHARMACEUTICALS, INC.. View Arrowhead Pharmaceuticals' (NASDAQ:ARWR) earnings history, MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Fundamental company data provided by Morningstar and Zacks Investment Research. View detailed financial information, real-time news, videos, quotes and analysis on Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR). Explore commentary on Arrowhead Pharmaceuticals Inc. and hear what the experts at TheStreet are saying about ARWR. ARWR $58.94 ($-0.86 -1.44%) ARWR is down $0.86 today, but where's it headed in 2020? Zacks Investment Research is releasing its prediction for ARWR based on the 1-3 month system that more than doubles the S&P 500. This report is free today for StockInvest.us readers. Click here – …